Convocatorias: Internacional

15th Call of Innovative Medicines Initiative – IMI2

Topics under consideration:

• Integrated research platforms enabling patient-centric drug development
• Blockchain enabled healthcare
• Microenvironment imposed signatures in tissue and liquid biopsies in immune mediated disease
• Emerging translational safety technologies and tools for interrogating human immunobiology
• Development and validation of translational platforms in support of synaptopathy drug discovery
• Digital endpoints in neurodegenerative and immune-mediated diseases
• AMR Accelerator programme Pillar A: Capability Building Network to accelerate and validate scientific discoveries
• AMR Accelerator programme Pillar B: Tuberculosis drug development network to accelerate and validate scientific discoveries and advance the R&D pipeline of new and innovative agents to address the global tuberculosis epidemic

16th Call of Innovative Medicines Initiative – IMI2

Topics:

• Progress new assets (one pre-new molecular entity preNME) and one first-time-in-human (FTIH) start for tuberculosis (TB) that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors.
• Progress nowel assets (one FYIH start) for non-tubercular mycobacteria (NTM) that may act synergistically with bedaquilene and cytochrome bc drugs.
• Discover and progress novel assets with new mechanisms of action (one preNME for TB and one preNME for NTM) and biomakers for TB and NTM infection.
• Determination of gepotidacin levels in tonsils and prostatic tissue.
• Infection site targeting, antibiotic encapsulated in nanoparticles for treating extracellular bacterial infections.
• Functional Ethionamide boosters: a novel combination for tuberculosis therapy.
• Intravenous treatments of serious infections (urinary tract infections (UTI), intra-abdominal infections (IAI) & hospital-acquired pneumonia/ventilator associated pneumonia (HAP/VAP)) caused by Gram(-) bacteria (Enterobacteriacease +/-, Pseudomonas and/or Acinetobacter).

Call for the HBP Infrastructure Voucher Programme: Projects can have, but are not limited to, the following broader goals:

• New software application
• New product or process development
• New customer interface
• New service development

Research Grants 2018

Ayudas dirigida a postdoctorales menores de 35 años para que desarrollen un proyecto de investigación relacionado con neurobiología en una institución francesa.

European Development Clinical Trials Partnerships (EDCTP-2):

• Strategic Action for overcoming drug resistance in Malaria 2018
• Vaccines for diarrheal deseases or lower respiratory tract infections 2018

CFF/NIH-Unfunded Award 2018

European Development Clinical Trials Partnership (EDCTP-2):

• Strategic Action for the comparasion, selection and development of Malaria vaccine candidates 2018

Clinic and Laboratory Integration Programme 2018

Ayudas para financiar proyectos de investigación relacionados con el uso de terapias inmunológicas en el tratamiento del cáncer

Project Concepts 2018-2

Ayudas a proyectos de investigación sobre Diabetes Tipo I

ERC Synergy Grant 2019